Antiphospholipid Antibodies in a General Obstetric Population: Clinical Impact on Pregnancy Outcome and Relationship with the M2 Haplotype in the Annexin A5 (ANXA5) Gene
暂无分享,去创建一个
G. Tiscia | M. Margaglione | E. Grandone | L. Greco | M. Intrieri | G. Maruotti | P. Martinelli | D. Colaizzo | E. Chinni | L. Fischetti | M. Villani | F. Cappucci
[1] E. Ota,et al. Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review , 2015, Lupus.
[2] G. Tiscia,et al. Genetic variations in the annexin A5 gene and the risk of pregnancy‐related venous thrombosis , 2015, Journal of thrombosis and haemostasis : JTH.
[3] P. D. de Groot,et al. Annexin A5 haplotypes in the antiphospholipid syndrome. , 2015, Thrombosis research.
[4] G. Tiscia,et al. The M2 haplotype in the ANXA5 gene is an independent risk factor for idiopathic small-for-gestational age newborns. , 2012, Molecular human reproduction.
[5] I. Kremensky,et al. The annexin A5 protective shield model revisited: inherited carriage of the M2/ANXA5 haplotype in placenta as a predisposing factor for the development of obstetric antiphospholipid antibodies , 2012, Lupus.
[6] B. Gallois,et al. Annexin-A5 assembled into two-dimensional arrays promotes cell membrane repair , 2011, Nature communications.
[7] G. Tiscia,et al. Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women , 2011, Journal of thrombosis and haemostasis : JTH.
[8] G. Tiscia,et al. Role of the M2 haplotype within the annexin A5 gene in the occurrence of pregnancy-related venous thromboembolism. , 2010, American journal of obstetrics and gynecology.
[9] P. Meroni,et al. The geoepidemiology of the antiphospholipid antibody syndrome. , 2010, Autoimmunity reviews.
[10] G. Tiscia,et al. Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications , 2009, Thrombosis and Haemostasis.
[11] G. Tiscia,et al. Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2. , 2009, Fertility and Sterility.
[12] A. Ruffatti,et al. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. , 2009, Thrombosis research.
[13] M. Krawczak,et al. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. , 2007, Human molecular genetics.
[14] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[15] J. Kruh,et al. Antiphospholipid antibody syndrome , 2012, Current opinion in ophthalmology.
[16] C. Infante-Rivard,et al. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. , 1992, The New England journal of medicine.